Table 1 Patient demographics and characteristics at baseline
Characteristic | Treatment-naïve (n = 42) | Previously treated (n = 270) | All (N = 312) |
|---|---|---|---|
Age, mean (SD), years | 52.5 (13.7) | 53.4 (14.5) | 53.3 (14.3) |
Gender, n (%) | |||
Male | 22 (52.4) | 156 (57.8) | 178 (57.1) |
Female | 20 (47.6) | 114 (42.2) | 134 (42.9) |
Diagnosis, n (%) | |||
OHT | 9 (21.4) | 21 (7.8) | 30 (9.6) |
OAG | 33 (78.6) | 249 (92.2) | 282 (90.4) |
Study eye, n (%) | |||
Right | 27 (64.3) | 171 (63.3) | 198 (63.5) |
Left | 15 (35.7) | 99 (36.7) | 114 (36.5) |
IOP, mean (SD), mm Hg | 18.0 (3.8) | 17.8 (3.9) | 17.9 (3.9) |
Patients previously treateda, n (%) | NA | ||
PGA monotherapy | 125 (46.3) | 125 (40.1) | |
Non-PGA monotherapy | 99 (36.7) | 99 (31.7) | |
PGA fixed-combination therapy | 5 (1.9) | 5 (1.6) | |
Non-PGA fixed-combination therapy | 17 (6.3) | 17 (5.4) | |
> 1 prior therapies | 24 (8.9) | 24 (7.7) | |
Patients with ≥ 1 medical comorbiditiesb, n (%) | 14 (33.3) | 160 (59.3) | 174 (55.8) |